Search

News

Ascenion is looking forward to a reunion with industry decision makers, venture capitalists, academic inventors and entrepreneurs. Eight from a total of 65 projects to be featured originate from Ascenion’s academic partners.

[Translate to English:]

A record number of 40 technology transfer colleagues joined Ascenion’s two-day workshop to connect with peers and to learn about the latest developments in patenting, AI, and structuring deals, spin-offs and equity.

[Translate to English:]

The US company Immusoft has dosed the first subject with its investigational engineered B cell therapy, ISP-001, in a human Phase I clinical trial of mucopolysaccharidosis type I (MPS I).

[Translate to English:]

dentalXrai and Tube Pharmaceuticals were both acquired by international key players in their respective fields. The transactions add new momentum, development and marketing power to the start-ups’ projects.

[Translate to English:]

Ascenion supports spin-offs from their partner institutes on their long-term growth trajectory. Recently, four of our portfolio companies have received different awards and prizes – sincere congratulations!

Through its spin-off program, Helmholtz Enterprise finances the establishment of start-up teams and the implementation of start-up projects in the Helmholtz Association.

Over the years, a strong clinical pipeline has arisen from our partners’ research projects, with the potential to provide enormous benefits for patients. Immerse yourself in all the details in our Annual Review, with selected projects, tips and figures.

[Translate to English:]

On 30 November 2023, Ascenion will host another GO-Bio Information Webinar as part of our BMBF-funded Life Science Digital Hub project.

[Translate to English:]

Beyza Yildiz has been supporting the Controlling team at the Munich head office since September 2023.

BioVaria 2024 will take place on 29/30 April at the Sofitel Munich. Technology transfer partners from several European countries will present around 70 commercially attractive projects. Application deadline for Startup Pitch & Partner is 15 February.

[Translate to English:]

The EU-funded AiChemist project aims to provide advanced AI approaches with increased explainability and broad applicability. It brings together key players from academia and industry and includes a structured training program for AI specialists.

[Translate to English:]

Leopard Biosciences GmbH, founded in July, is developing a new diagnostic platform that can detect multiple markers in a single test. The translation of the technology was made possible by funding from the Helmholtz Association.

Our next Life Science Digital Hub workshop will take place on August 24, 2023.

[Translate to English:]

Ten female-led startups competed in the finale of the Female StartAperitivo startup competition. Ascenion’s portfolio company TimeTeller received the most votes in the public ballot for a method to make chemotherapy more effective and less harmful to the patient.

Ascenion's portfolio company OMEICOS has received a significant grant by the German Federal Ministry of Education and Research (“BMBF”) to co-finance a Phase 2a study evaluating their lead product candidate OMT-28 in Primary Mitochondrial Disease (PMD) patients.

Events

[Translate to English:]

BioVaria 2024

Sofitel Munich Bayerpost
Munich, Germany

TA Conference

Frankfurt am Main, Germany

 

[Translate to English:]

ASTP Annual Conference

Seville, Spain

 

BioFIT 2024

Lille, France